CapsulesClinical Overview
Levosalbutamol (50mcg/100mcg) and Beclomethasone Dipropionate (50mcg/100mcg/200mcg Inhaler, Rotacaps) combines the active (R)-enantiomer of salbutamol with a synthetic glucocorticoid. Levosalbutamol provides rapid-acting selective beta-2 bronchodilation without the adverse tachycardia, tremor, and pro-inflammatory effects associated with the inert (S)-isomer. Beclomethasone suppresses underlying eosinophilic airway inflammation and edema. Indicated for maintenance and symptomatic treatment of mild-to-moderate bronchial asthma.
Active Pharmaceutical Ingredients
Verified Clinical References
Usage Guidelines
Inhale 1 to 2 puffs or 1 rotacap twice daily. Rinse mouth and spit out water following each use.
General Administration Advice: Adhere strictly to the prescribed dosage, frequency, and treatment course. For oral medications, swallow with sufficient water. Never stop antibiotics, psychiatric medications, or antihypertensives abruptly without clinical direction.
Possible Side Effects
Common: Oropharyngeal candidiasis, dysphonia, throat irritation, mild tremor, palpitations. Rare/Severe: Paradoxical bronchospasm, hypokalemia, and hypersensitivity.
*Note: Individual physiological responses vary. While many patients experience few or no side effects, notify your treating physician if adverse reactions persist or if hypersensitivity (angioedema, skin rash, dyspnea) occurs.
Precautions & Warnings
Rinse mouth with water after each use. Do not swallow rotacaps. Maintain regular use even when asymptomatic.
Medical Disclaimer: Statutory Clinical Disclaimer: The information provided is for educational and price-transparency purposes only and does not constitute medical advice, pulmonological diagnosis, or respiratory management recommendations. Inhalation therapies and allergy medications should be used strictly under the guidance of a qualified pulmonologist or registered medical practitioner.
Beclomethasone Dipropionate 0.025%, Clotrimazole 1% and Gentamicin Sulphate 0.1% Cream
Clotrimazole (1% w/w cream, lotion, or dusting powder) is a versatile broad-spectrum imidazole antifungal on the WHO Model List of Essential Medicines. It inhibits fungal cytochrome P450 14-alpha-demethylase, depleting ergosterol and increasing fungal cell permeability. Dusting powder formulation absorbs excess moisture in intertriginous skin folds, preventing fungal maceration. Indicated for tinea pedis, tinea cruris, tinea corporis, cutaneous candidiasis, and prevention of recurrence in sweaty body folds.
Beclomethasone 0.025% and Neomycin 0.5% Cream
Beclomethasone 0.025% and Neomycin 0.5% Cream is an evidence-based dermatological formulation. It acts by delivering targeted active therapeutic ingredients to cutaneous lesions to relieve skin pathology, restore barrier integrity, and manage dermatoses.
Levosalbutamol 1.25mg + Ipratropium 500mcg Respules
Salbutamol (100mcg) and Ipratropium Bromide (20mcg Inhaler) combines a short-acting beta-2 agonist (SABA) with a short-acting muscarinic antagonist (SAMA) on the WHO Model List of Essential Medicines. Salbutamol relaxes bronchial smooth muscle via cyclic AMP elevation; ipratropium blocks vagal acetylcholine-mediated bronchoconstriction at muscarinic M3 receptors. This dual-pathway approach produces greater, longer-lasting bronchodilation than either agent alone without added sympathomimetic side effects. Indicated for management of bronchospasm in Chronic Obstructive Pulmonary Disease (COPD) and acute severe asthma exacerbations.
Ambroxol Hydrochloride 15 mg + Guaifenesin 50 mg + Levosalbutamol Sulphate 1 mg Syrup
Salbutamol Tablets (2mg, 4mg) and Syrup (2mg/5ml) is an oral selective beta-2 adrenergic receptor agonist on the WHO Model List of Essential Medicines. Relaxes bronchial smooth muscle via adenylyl cyclase activation. Indicated for relief of bronchospasm in asthma and reversible obstructive airway disease when inhalation devices cannot be used (e.g. young children or severely arthritic patients).